跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IRINOTESIN CONCENTRATE FOR INF 100MG/5ML - PPB Drug Approval Details
Approvals
/
PPB
/
IRINOTESIN CONCENTRATE FOR INF 100MG/5ML
Approved
STANDARD
IRINOTESIN CONCENTRATE FOR INF 100MG/5ML
TEVA PHARMACEUTICAL HONG KONG O/B TEVA PHARMACEUTICAL HONG KONG LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
186d51d07edbb6cb
Company
TEVA PHARMACEUTICAL HONG KONG O/B TEVA PHARMACEUTICAL HONG KONG LIMITED
Type
Standard
Approval Details
Approval Id
186d51d07edbb6cb
Product Name
IRINOTESIN CONCENTRATE FOR INF 100MG/5ML
Drug Hk Name
IRINOTESIN CONCENTRATE FOR INF 100MG/5ML
Registration Code
HK-58691
Company Name
TEVA PHARMACEUTICAL HONG KONG O/B TEVA PHARMACEUTICAL HONG KONG LIMITED
Company Detail Path
/organization/teva-pharmaceutical-hong-kong-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2009-10-30
Company Address
FLAT/RM 2303, 23/F, MIRA PLACE TOWER A, 132 NATHAN ROAD, TSIM SHA TSUI, KOWLOON
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
186d51d07edbb6cb
Type
Standard
Back to PPB Approvals